1st Training School news
We held the first IDP2Biomed Training School in Cambridge. It featured excellent scientific discussions on drug design targeting disordered proteins and on possible approaches to addressing the challenge of structural heterogeneity. The main focus of the training was to gain a deeper understanding of the abnormal cellular processes involved in cancer and neurodegenerative diseases (such as ALS and Parkinson’s disease), with particular emphasis on the mechanisms of phase separation and aggregation, drug design targeting these processes, and the development of related computational and experimental methods.
